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Abstract
Background: A major boost to cystic fibrosis disease research was given by the generation of
various mouse models using gene targeting in embryonal stem cells. Moreover, the introduction of
the same mutation on different inbred strains generating congenic strains facilitated the search for
modifier genes. From the original CftrTgH(neoim)Hgu mouse model with a divergent genetic background
(129/Sv, C57BL/6, HsdOla:MF1) two inbred mutant mouse strains CF/1-CftrTgH(neoim)Hgu and CF/3-
CftrTgH(neoim)Hgu had been generated using strict brother × sister mating. CF/1-CftrTgH(neoim)Hgu and CF/
3-CftrTgH(neoim)Hgu mice were fertile and showed normal growth and lifespan. In this work the
CftrTgH(neoim)Hgu insertional mutation was backcrossed from CF/3-CftrTgH(neoim)Hgu onto the inbred
backgrounds C57BL/6J and DBA/2J generating congenic animals in order to clarify the differential
impact of the Cftr mutation and the genetic background on the disease phenotype of the cystic
fibrosis mutant mice. Clinical and electrophysiological features of the two congenic strains were
compared with those of CF/1-CftrTgH(neoim)Hgu and CF/3-CftrTgH(neoim)Hgu and wild type controls.
Results: Under the standardized housing conditions of the animal facility, the four mouse strains
CF/1-CftrTgH(neoim)Hgu, CF/3-CftrTgH(neoim)Hgu, D2.129P2(CF/3)-CftrTgH(neoim)Hgu  and B6.129P2(CF/3)-
CftrTgH(neoim)Hgu exhibited normal life expectancy. Growth of congenic cystic fibrosis mice was
comparable with that of wild type controls. All mice but D2.129P2(CF/3)-CftrTgH(neoim)Hgu females
were fertile. Short circuit current measurements revealed characteristic response profiles of the
HsdOla:MF1, DBA/2J and C57BL/6J backgrounds in nose, ileum and colon. All cystic fibrosis mouse
lines showed the disease-typical hyperresponsiveness to amiloride in the respiratory epithelium.
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The mean chloride secretory responses to carbachol or forskolin were 15–100% of those of the
cognate wild type control animals.
Conclusion: The amelioration of the clinical features and of the basic defect that had emerged
during the generation of CF/3-CftrTgH(neoim)Hgu mice was retained in the congenic mice indicating that
the Cftr linkage group or other loci shared between the inbred strains contain(s) the major
modifier(s) of attenuation of cystic fibrosis symptoms.
Background
Cystic fibrosis (CF) is a severe monogenic disorder of ion
transport in exocrine glands [1]. Mutations in the CF trans-
membrane conductance regulator (CFTR) gene lead to
impaired epithelial chloride secretion. Dehydration and
plugging of mucous secretions in the ducts of exocrine
glands predispose to multiorgan clinical manifestations,
particularly in the gastrointestinal, hepatobiliary, repro-
ductive and respiratory tracts. In the intestine the chloride
and fluid secretion are impaired while sodium and
sodium-linked nutrient absorption are enhanced. The
resulting dehydration of luminal contents contributes to
many of the gastrointestinal manifestations of CF, includ-
ing the meconium ileus of the neonate [1].
Several mouse models of CF were generated by gene tar-
geting approaches whereby either the murine Cftr gene
was disrupted or CF mutations were introduced into the
murine Cftr gene at homologous positions. These mouse
models typically exhibit a severe phenotype with intesti-
nal obstruction that is physiologically very similar to the
meconium ileus observed in humans with CF [2,3].
The transgenic CftrTgH(neoim)Hgu mouse model was gener-
ated by Dorin et al. [4] using an insertional gene targeting
vector to disrupt exon 10 of the Cftr gene in 129P2 embry-
onic stem cells. Unlike the Cftr mutants created by gene
replacement, the CftrTgH(neoim)Hgu mutant mice showed a
surprisingly high rate of survival because low levels of
wild type Cftr mRNA were produced as a result of exon
skipping and aberrant splicing [5]. The original outbred
CftrTgH(neoim)Hgu mouse suffered from only mild intestinal
obstruction, but otherwise it exhibited typical features of
CF such as abnormal profiles of epithelial ion flow [4,6],
mucus accumulation in gut and reproductive tracts [4]
and reduced alveolar [7] and mucociliary clearance [8].
Mice from the original outbred CftrTgH(neoim)Hgu  mouse
population with a mixed genetic background (129P2,
C57BL/6, HsdOLA:MF1) were used as founder animals to
establish the CF/1-CftrTgH(neoim)Hgu  (CF/1) and CF/3-
CftrTgH(neoim)Hgu (CF/3) inbred mouse strains by brother ×
sister mating for currently more than 40 generations [9].
When we started inbreeding, perinatal mortality was
observed that peaked at the time of weaning when 8–10%
of litter died of intestinal obstruction [7]. Survival was
76% at the age of 3 months for the F8 – F10 generations.
CF/1 and CF/3 mice of generation 25 or more, however,
did not show any increased mortality over wild type ani-
mals (pre- or post weaning) [10]. Both males and females
were fertile. F27 – F32 CF/1 and CF/3 mice presented nor-
mal electrophysiology in the respiratory and intestinal
epithelium, although the amounts of the expressed wild
type Cftr mRNA and protein were less in the CF/3 than in
the CF/1 strain [10]. Thus, inbreeding by brother × sister
mating rescued from CF although the insertion mutation
in exon 10 of the Cftr gene had been retained.
We reasoned from the close-to-normal phenotype of the
CF/1 and CF/3 mice that beneficial alleles had been
selected from the outbred ancestors which ameliorated
the basic defect and led to close-to-normal growth,
lifespan and fertility under our housing conditions. The
role of secondary genetic factors for the survival of CF
mice has already been demonstrated in Cftr1HSC knock-out
mice that had been generated on a mixed genetic back-
ground by the disruption of exon 1 of the Cftr gene [11].
Severe intestinal obstruction led to death within the first
two weeks of life or around the time of weaning in the
majority of animals, but 30% of mice survived past six
weeks of age. The original founder mouse was crossed
with different inbred strains to generate F1 mice of differ-
ent genetic backgrounds and the heterozygous F1 mice
were intercrossed to produce homozygous knockout
mice. The C57/BL6 cross yielded CF knock-out mice at
Mendelian ratios with 25% long-term surviviors. In con-
trast, the numbers of CF mice of the cross with DBA/2J
were much less than expected from Mendelian segrega-
tion and perinatal mortality was more than 90%. Electro-
physiological studies on the mice with prolonged survival
showed an upregulation of a calcium-regulated chloride
conductance. This data demonstrated that the C57BL/6
background contained genetic modifier(s) associated
with survival and expression of alternative chloride chan-
nels that were apparently missing in the DBA/2J back-
ground.
Since the C57BL/6 and DBA/2J backgrounds caused diver-
gent phenotypes in CF knock-out mice, we hypothesized
that the same genetic backgrounds could also be strong
modifiers of the phenotype of CF mice carrying the 'leaky'
CftrTgH(neoim)Hgu insertion mutation. To address this issue,BMC Genetics 2008, 9:28 http://www.biomedcentral.com/1471-2156/9/28
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the insertional mutation was backcrossed from CF/3 onto
the inbred backgrounds C57BL/6J and DBA/2J generating
the D2.129P2(CF/3)-CftrTgH(neoim)Hgu  (D2-CF/3) and
B6.129P2(CF/3)-CftrTgH(neoim)Hgu  (B6-CF/3) congenic
mouse strains. These congenic mice should retain the Cftr
linkage group of CF/3 but otherwise should be
homozygous for C57BL/6J or DBA/2J alleles, respectively.
Hence the comparison of the phenotype of CF/3 with that
of the congenic mice could also resolve the fundamental
question whether the rescue from CF in CF/3 mice was
caused by secondary factor(s) in the Cftr linkage group
and/or by loci somewhere else in the genome. Here we
report on the clinical and electrophysiological features of
CF/1, CF/3, the two congenic strains amd their wild type
controls. The D2-CF/3 and B6-CF/3 congenic mice had
retained some CF-typical signature of ion flow in the
upper respiratory tract, ileum and colon, but they also
showed substantial chloride secretory responses close to
wild type behaviour like CF/3 in the intestine. Thus, in
contrast to the observations in the Cftr1HSC knock-out
mice, the inbred CftrTgH(neoim)Hgu – derived mouse strains
CF/1, CF/3, D2-CF/3 and B6-CF/3 were all able to correct
the CF phenotype and presumably share the major modi-
fier(s) of attenuation of CF symptoms.
Results
Genotyping
In CftrTgH(neoim)Hgu mice the exon 10 of the Cftr gene is dis-
rupted by the insertion of the vector pMCIneoPolyA [4].
This construct was crossed from CftrTgH(neoim)Hgu transgenic
CF mice into the DBA/2J and C57BL/6J backgrounds via
heterozygous carriers of the mutation. The vector insert is
known to be excised at low frequency in heterozygous car-
riers of mutant and wild type alleles [9]. Hence all CF mice
of this study that were subjected to electrophysiological
analysis were typed at the Cftr locus in order to verify their
CF genotype. All typed D2-CF/3, B6-CF/3, CF/1 and CF/3
mice were carrying the pMCIneoPolyA insertion at the
same integration site in exon 10 of the Cftr gene and were
homozygous for the same intragenic Cftr 3-marker micro-
satellite haplotype like their CF/3 founders [see Addi-
tional file 1]. This data demonstrated that the two
congenic mouse lines shared the organization of the Cftr
locus with that of CF/1 and CF/3 mice.
Next, the genetic background of DBA/2J, C57BL/6J and
the four CF lines was compared in 26 SNPs whereby each
murine chromosome was represented by one or two SNPs
[see Additional file 1]. The congenic D2-CF/3 and B6-CF/
3 mice shared the SNP genotypes with wild type DBA/2J
and C57BL/6J mice. The exception was SNP rs3023064
located 0.5 Mbp upstream of Cftr where all typed B6-CF/
3 mice had the same genotype as the CF/3 strain [see
Additional file 1]. The shared SNP genotype profile indi-
cated that D2-CF/3 and B6-CF/3 were congenic mouse
lines. This conclusion could however have been flawed by
the low informativeness of the marker set. The six inbred
strains were identical in genotype for 7 of the 26 SNPs. To
allow an unequivocal discrimination between the inbred
strains, we selected a set of five informative microsatellites
for further genotyping [see Additional file 1]. This marker
set concurrently differentiated the closely related CF/1
and CF/3 and the unrelated DBA/2J, C57BL/6J and CF/3
from each other. D2-CF/3 and B6-CF/3 shared
homozygous microsatellite genotypes with DBA/2J and
C57BL/6J wild type, respectively. Thus, the profile of
marker genotypes indicated that both D2-CF/3 and B6-
CF/3 strains were congenic and were harbouring the same
sequence as CF/3 mice at Cftr and adjacent loci.
Growth and reproduction
Male mice had significantly higher body weight than
females of the same age in all investigated mouse strains
but D2-CF (Tables 1 and 2). With the exception of C57BL/
6J males, body weight was similar for wild type and the
corresponding congenic CF mice of the same gender indi-
cating that the 'leaky' insertion mutation [5] did not sig-
nificantly affect growth. Inbred CF/1 and CF/3 mice were
heavier than the congenic CF mice of the same age and
gender in accordance with the lower body weight of wild
type inbred lines DBA/2J and C57BL/6J compared to out-
bred HsdOla:MF1 (Tables 1 and 2). Body weight of CF/1
and CF/3 mice of both sexes was similar to that of DBA/2J
males, but higher than that of DBA/2J females. Similarly,
CF/1 females were heavier than C57BL/6 females. In sum-
mary, gender and genetic background were more impor-
tant than the CftrTgH(neoim)Hgu mutation in shaping body
weight.
The inbred CF/1, CF/3 and B6-CF/3 mice were fertile in
the homozygous CF state. D2-CF/3 females, however,
were not fertile. Hence, the line was propagated by cross-
ing D2-CF/3 males with female heterozygous carriers of
the  CftrTgH(neoim)Hgu  mutation. Tables 3 and 4 provide
information about the reproductive fitness of the investi-
gated strains. Wild type C57BL/6 mice generated the high-
est number of offspring. Litter size of the congenic B6-CF/
3 strain was comparable, but the number of litters per
breeding pair was lower than that of the wild type strain
(P  < 0.01). CF/1 and CF/3 mice produced the lowest
number of litters. Litter size, however, was normal. CF/3
mice generated more progeny per litter than DBA/2J and
as many as C57BL/6J mice (Table 3).
Survival rates beyond weaning were 81% and 91% for
wild-type DBA/2J and C57BL/6J, both 87% for the two
congenic strains D2-CF/3 and B6-CF/3, 86% for CF/1 and
91% for CF/3. Under our housing conditions death rates
during the perinatal and weaning periods were not higher
than in wild type mice for all four inbred CF mouse lines.BMC Genetics 2008, 9:28 http://www.biomedcentral.com/1471-2156/9/28
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Electrophysiology
Aberrant epithelial ion flow is the hallmark of the basic
defect in CF [1]. We investigated the secretory responses of
nasal, ileal and colon epithelia upon exposure to secreta-
gogues and channel blockers in the four inbred
CftrTgH(neoim)Hgu strains and their corresponding wild type
controls. The outcome of the Ussing chamber measure-
ments is summarized in the histograms of Figure 1.
Table 1: Body weights of the investigated mice.
Strain Age (days, mean ± SD) Generation Number of mice Weight (g)
DBA/2J 118.4 ± 8.3 F 167-F 169 9  21.7 ± 0.5
9  27.6 ± 2.6
C57BL/6J 113.7 ± 8.4 F 166-F 170 9  21.2 ± 2.0
9  31.7 ± 2.6
HsdOla:MF1 140.4 ± 2.1* no data 9  37.7 ± 4.8
9  43.4 ± 5.1
D2.129P2(CF/3)-CftrTgH(neoim)Hgu 114.6 ± 5.7 N10F 9-F 12 9  20.8 ± 2.7
9  23.7 ± 3.0
B6.129P2(CF/3)-CftrTgH(neoim)Hgu 107.8 ± 8.9 N12F 8-F 12 9  20.4 ± 0.9
9  26.1 ± 2.1
CF/1-CftrTgH(neoim)Hgu 111.9 ± 8.7 F 27-F 40 9  25.4 ± 1.8
9  29.9 ± 3.3
CF/3-CftrTgH(neoim)Hgu 122.1 ± 8.1 F 27-F 40 9  24.4 ± 2.9
9  31.3 ± 2.5
DBA/2J§ 112  Jaxpheno1: 24.4
Jaxpheno2: 27.0
Jaxpheno5: 24.9
 Jaxpheno1: 28.6
Jaxpheno2: 29.2
Jaxpheno5: 28.9
C57BL/6J§ 112  Jaxpheno1 21.9
Jaxpheno2: 22.0
Jaxpheno5: 22.1
 Jaxpheno1: 29.1
Jaxpheno2: 30.5
Jaxpheno5: 30.0
* The body weight of HsdOla:MF1 mice by the age of 120 ± 9 days had been determined in a previous study [7] to be 31 ± 2 g.
§Data were obtained from the Mouse Phenome Database of the Jackson Laboratory, Bar Harbor, Maine, USA [33].
Table 2: Significance of differences in mean body weight differentiated by strain and gender
DBA/2J C57BL/6J HsdOla:MF1 D2-CF/3 B6-CF/3 CF/1 CF/3
        
DBA/2J  *** * ** na na ns * ns *** ns ns ns ns
 *** ns na na ns ns ** * *** ** *** *
C57BL/6J  *** na na ** *** ** *** ns ** ns **
 na na ns ns * ns ** * *** ns
Hsd Ola: MF1  * n an an an an a n a n a n a
 na na na na na na na na
D2-CF/3  ns ns ns * ns ** ns
 * ns ** * *** ns
B6-CF/3  *** ns ns * ns
 *** ** *** *
CF/1  *n s*
 ** ns
CF/3  **

*, P < 0.05; **, P < 0.01; ***, P < 0.001; ns, not significant na, not applicable because of the higher age of HsdOla:MF1 miceBMC Genetics 2008, 9:28 http://www.biomedcentral.com/1471-2156/9/28
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CF nasal epithelium was exposed to the sodium channel
blocker amiloride (Fig. 1A). Whereas all wild type mouse
strains showed a minute response to amiloride, nasal tis-
sues of all four CF mouse strains responded with a
decrease of the short circuit current within the range of 1
µEqh-1cm-2. Next, forskolin was added which activates
adenylate cyclase, production of cAMP and subsequent
opening of cAMP-dependent chloride conductances. For-
skolin evoked a stronger chloride secretory response in
wild type than in the corresponding CF nasal epithelium
in accordance with the expectation that forskolin should
elicit a larger luminal flow of chloride in Cftr-proficient
than in Cftr-compromised mice (Fig. 1B). This difference
was particularly pronounced in the two congenic CF
strains, although – due to the large scatter of values of
individual DBA/2J mice – it was only significant for the
comparison between C57BL/6J and B6-CF/3 mice. The
genetic background was as least as important as the non-
CF vs. CF state for luminal chloride flow. The CF strains
CF/1 and CF/3, for example, showed a similar chloride
secretory response as the non-CF DBA/2J and C57BL/6J
mice.
Next, the chloride secretory responses upon stimulation
with carbachol or with the cAMP agonist forskolin and the
phosphodiesterase inhibitor genistein were measured in
the mouse ileum which is the site of the most profound
pathology in most CF mouse models, namely the fatal
intestinal obstruction syndrome [2,3,11]. This complica-
tion was absent in all four strains CF/1, CF/3, B6-CF/3 and
D2-CF/3. The proximal intestine is known to express
numerous anion transporters, exchangers and channels,
of which CFTR is the major respondent upon activation
with forskolin [12]. The addition of forskolin and genis-
tein stimulated statistically indistinguishable short circuit
currents in the ileum of all seven tested mouse strains (Fig.
1D). The interindividual response within a strain was
more variable than the mean interstrain difference sug-
gesting that at least in the ileum all four CF strains pro-
duced sufficient Cftr and/or other chloride conductances
to mount a normal or close-to-normal chloride secretory
response.
Carbachol was the other agonist to stimulate chloride
secretion. Carbachol initiates the cholinergic activation of
chloride secretion by increasing the intracellular Ca2+ con-
centration through stimulation of Ca2+ influx and mobili-
zation of intracellular Ca2+ stores [13]. This causes Ca2+
dependent K+ efflux, which acts as the electrogenic driving
force for apical chloride secretion [14]. Moreover, carba-
chol activates CFTR in the apical membrane by increasing
the formation of diacylglycerol, thus stimulating the pro-
tein kinase C – dependent signaling pathway [15]. A large
transient chloride secretory response upon addition of
carbachol, i.e. an increase of Isc, is characteristic for intes-
tinal epithelia and is caused mainly by CFTR-mediated
chloride secretion [16].
The mean chloride secretory response of the tested mice to
serosal application of carbachol was 1.3- to 3-fold
stronger in wild-type than in their corresponding
CftrTgH(neoim)Hgu strain(Fig. 1C). However, pairwise com-
parisons revealed significantly larger Isc only between the
outbred HsdOla:MF1 and the four CF strains (Fig. 1C).
The ileal epithelium of CF/1 and CF/3 showed a similar
Isc response as that of wild type C57BL/6J mice. In other
words, genetic loci other than Cftr influenced the response
to carbachol.
Table 3: Fertility of mouse strains
Strain Generation No of breeding pairs No of litters per breeding pair Litter size
Median (inner quartiles; range)
DBA/2J F 167-F 169 7 4 (3–7; 1–14) 4 (2–5; 1–8)
C57BL/6J F 166-F 170 68 6 (5–8; 2–10) 6 (4–8; 1–11)
D2.129P2(CF/3)-CftrTgH(neoim)Hgu N10F 9-F 12 19 4 (3–7; 1–10) 4 (2–5; 1–10)
B6.129P2(CF/3)-CftrTgH(neoim)Hgu N12F 8-F 12 21 4 (3–5; 1–7) 5 (3–7; 1–11)
CF/1-CftrTgH(neoim)Hgu F 27-F 40 106 3 (2–4; 1–10) 5 (3–6; 1–10)
CF/3-CftrTgH(neoim)Hgu F 27-F 40 93 3 (2–3; 1–8) 6 (4–7; 1–10)
Table 4: Significance of interstrain differences of fertility (litter 
size and number of litters per breeding pair)
No. of litters per breeding pair
DBA/2J C57BL/6J D2-CF/3 B6-CF/3 CF/1 CF/3
DBA/2J ns ns ns *** ***
C57BL/6J ns ns ** *** ***
D2-CF/3 ns ** ns *** ***
B6-CF/3 ns ns ns ns *
CF/1 ns *** * ns ns
CF/3 * ns *** ns **
Litter size
*, P < 0.05; **, P < 0.01; ***, P < 0.001; ns, not significantBMC Genetics 2008, 9:28 http://www.biomedcentral.com/1471-2156/9/28
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Short circuit current measurements in the epithelia of the upper respiratory tract (A, B, n = 4 per mouse line), ileum (C, D, n  = 4) and colon epithelium (E, n = 10) in inbred CftrTgH(neoim)Hgu mouse strains and their cognate wild type controls Figure 1
Short circuit current measurements in the epithelia of the upper respiratory tract (A, B, n = 4 per mouse line), ileum (C, D, n 
= 4) and colon epithelium (E, n = 10) in inbred CftrTgH(neoim)Hgu mouse strains and their cognate wild type controls. ∆Isc repre-
sents the change in short circuit current from baseline after addition of either amiloride (A), forskolin (B), forskolin + genistein 
(D) and carbachol (C, E). * P < 0.05; ** P < 0.01; *** P < 0.001.BMC Genetics 2008, 9:28 http://www.biomedcentral.com/1471-2156/9/28
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The high levels of Cftr mediated chloride secretion in the
ileum of the congenic CF mice were unexpected, although
it corresponded to their uniform mild phenotype. To
address the issue if a substantial carbachol-induced chlo-
ride secretory response was a general feature of the intes-
tine of congenic mice, we also measured the carbachol
response in the colon. The number of animals in each
group was increased in order to unequivocally answer the
question whether or not isogenic non-CF and
CftrTgH(neoim)Hgu mouse strains could be differentiated by
their transient chloride secretory response to carbachol
which is the basis for the diagnosis of CF in intestinal cur-
rent measurements in humans [17,18]. Moreover the pro-
tocol was modified so that the carbachol response should
almost exclusively be caused by Cftr-mediated chloride
secretion. The proximal and distal specimens from the
colon ascendens were preincubated with amiloride, TEA
and BaCl2 in order to block the apical Na+ and K+ conduct-
ances. Subsequently, the tissues were preincubated with
DIDS prior to carbachol addition. DIDS does not affect
the Cftr channel from the extracellular side at physiologi-
cal pH, but it blocks other chloride conductances such as
the CaCC and ORCC [19,20].
Taking a size of ten animals per group and following the
modified protocol, the change of short circuit current in
colonic epithelium induced by carbachol was significantly
lower in all CF strains than in their wild type controls (Fig.
1E), although the values recorded for individual CF and
non-CF mice were overlapping. Mean Isc values of the D2-
CF/3 and the B6-CF/3 strain were 63% and 51% of those
of DBA/2J and C57BL/6J mice, respectively. In contrast to
the findings in the nasal and ileal epithelia, the mice with
the DBA/2J and C57BL/6J backgrounds mounted stronger
chloride secretory responses in the colon to carbachol
than HsdOla:MF1 and the derived CF/1 and CF/3 mice.
Carbachol-stimulated chloride secretion was within the
same range in colon and ileum of the three latter strains
with MF1 background. In contrast, the response was 4-
fold higher in the colon than in the ileum of the other four
investigated strains (Figs. 3C, 3E). Hence, the genetic
backgrounds divergently influenced absolute and relative
levels of Cftr-mediated chloride secretion in the proximal
and distal intestine.
Discussion
The analysis of four inbred CftrTgH(neoim)Hgu mouse strains
and their wild type controls allowed us to address two
basic complementary aspects of genotype-phenotype
association studies.
First, a CF congenic strain should only differ at the Cftr
chromosomal region from the wild type, and hence the
comparison between CF and non-CF mice should dissect
the role of the CftrTgH(neoim)Hgu mutation on murine pheno-
type in this particular genetic background. The CF basic
defect of hyperresponsiveness to amiloride and lower
chloride secretory responses to carbachol and cAMP ago-
nists [1] was common for all CftrTgH(neoim)Hgu mutant mice.
Severe macroscopic pathology or CF-typical clinical fea-
tures, however, were not observed. This very mild pheno-
type that particularly was not anticipated for the congenic
strains with the DBA/2J or C57BL/6J backgrounds, is in
sharp contrast to the severe phenotype of CF mice that
carry null mutations in the same genetic backgrounds
[21,22].
Second, the comparison of numerous CftrTgH(neoim)Hgu
strains should reveal the role of non-Cftr genes on the
phenotype of CF mice with the same disease-causing
mutation. The most remarkable findings were strain-spe-
cific signatures of weight gain and of secretagogue-
induced ion flow and the reduced fertility of female D2-
CF/3 mice not seen in any of the other three inbred
CftrTgH(neoim)Hgu strains. Insufficient weight gain, infertility
and aberrant epithelial ion flow are key features of CF [1].
By using our inbred CftrTgH(neoim)Hgu mouse models, the
murine loci could be mapped that account for these
strain-specific differences in phenotypic traits that are rel-
evant for human CF disease. The comparison of the same
Cftr  mutation in different genetic backgrounds has
already been employed by Haston and colleagues to iden-
tify modifier loci of the CF phenotype in lung [22], intes-
tine [23] and body weight [24] by quantitative trait loci
mapping of C57BL/6J and BALB/c mice carrying the
Cftrtm1UNC null mutation.
The four inbred CftrTgH(neoim)Hgu mouse strains exhibited a
very mild CF phenotype under the standardized living
conditions in our animal facility as indicated by close-to-
normal growth and lifespan and a substantial chloride
secretory response to carbachol and forskolin of 15 –
100% of wild-type levels. Weight gain and survival of the
CF/1 and CF/3 mice continuously improved with the
number of brother × sister matings that had been started
from four outbred littermates [10]. Whereas the initial
outbred transgenic CftrTgH(neoim)Hgu mutant mice exhibited
typical pathophysiological features of CF in gut, lung and
reproductive tract [4,6,7], the CF/1 and CF/3 mice of gen-
eration 20 or more ameliorated the basic defect and
showed normal survival [10]. This favourable phenotype
was retained when the CftrTgH(neoim)Hgu insertional muta-
tion was introduced from inbred CF/3 mice into the
C57Bl/6J and DBA/2J backgrounds. Hence, we would like
to conclude that the close-to-normal phenotype of the
four  CftrTgH(neoim)Hgu strains results from positive modi-
fier(s) located in sequences shared by all mice, namely
Cftr  and hitchhiking loci in cis, although we cannot
exclude that some CF/3 sequences elsewhere in the
genome were under such a strong positive selection dur-BMC Genetics 2008, 9:28 http://www.biomedcentral.com/1471-2156/9/28
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ing the production of the congenic mice that they had
been retained in the D2-CF/3 and B6-CF/3 strains.
Although the typical clinical aspects of CF such as under-
weight and poor survival were not seen in the four inbred
CftrTgH(neoim)Hgu  mouse lines, we nevertheless observed
some CF-typical features in our clinically inconspicuous
mice. The functional assessment of the upper respiratory
epithelium uncovered a CF-typical electrophysiological
phenotype. Besides a lower response to forskolin, a strong
hyperresponsiveness to amiloride was noted in all
CftrTgH(neoim)Hgu strains. Previous semiquantitative immu-
noblot analysis of CF mouse tissue indicated that about
10–15 % of Cftr wild type protein levels are sufficient to
normalize Cftr – mediated chloride secretion [10,25], but
do not correct the hyperabsorption of sodium ions. This
finding agrees with the outcome of CFTR gene transfer
into human CF airway epithelial cells that subnormal lev-
els of CFTR restore cAMP-mediated chloride secretion, but
that the normalization of sodium hyperabsorption fol-
lows a linear dose-response relationship [26,27,32]. In
summary, the basic electrophysiological defect of CF was
apparent in all tissue comparisons between CF and non-
CF strains with the same genetic background, although it
was more visible in the nose than in ileum and colon.
The most unexpected finding of our study was the clini-
cally asymptomatic phenotype of the congenic D2-CF/3
and B6-CF/3 mice. It seemed as if the pathophysiological
consequences of the Cftr  insertion mutation had been
neutralized by beneficial modifiers. However, we cannot
yet exclude that the mild phenotype is at least partially
based upon the favourable living conditions in the animal
facility with its unrestricted access to food and prevention
from pathogens. Fitness differences between congenic CF
and non-CF mice may become apparent in the wild.
Future studies of how CftrTgH(neoim)Hgu mouse strains can
cope with CF-typical stress conditions could resolve this
issue.
Conclusion
Brother × sister matings over 40 generations switched the
mild phenotype of the original outbred CftrTgH(neoim)Hgu
mouse to close-to-normal clinical phenotypes of inbred
CF/1 and CF/3 mice. Transfer of the mutated Cftr locus
into the standard backgrounds DBA/2J and C57BL/6J
retained this very mild phenotype. CF-typical bioelectrics
were still seen in the congenic CF mice and allowed a dif-
ferentiation between CF and non-CF states, although not
at the level of the individual animal. With the exception
of fertility of D2-CF/3 females, residual chloride secretion
was sufficiently large for having no clinical consequences.
The mild phenotype of CF/1, CF/3, B6-CF/3 and D2-CF/3
mice indicates that loci shared between the inbred strains,
most likely the Cftr  linkage group, contain the major
modifier(s) of attenuation of CF symptoms.
Methods
Experimental animals
Offspring (generation F4) of the original CftrTgH(neoim)Hgu
mouse population with divergent genetic backgrounds
originating from the 129/Sv, C57BL/6 and HsdOla:MF1
strains [4] were used to generate the CF/1 and CF/3 inbred
mouse strains by brother × sister mating at the Central
Animal Facility of the Hannover Medical School [9]. Con-
genic mouse strains were generated on DBA/2J and
C57BL/6J backgrounds by using CftrTgH(neoim)Hgu mice as a
donor strain establishing the D2-CF/3 and B6-CF/3
strains [9,28] by speed congenic production [29].
All experiments were approved by the local government as
well as by the local Institutional Animal Care and
Research Advisory Committee. All mice were bred in the
Central Animal Facility of the Hannover Medical School,
except for the HsdOla:MF1 strain. Mice of this strain had
been bred by Harlan Winkelmann GmbH (Borken, Ger-
many) and were shipped to the Central Animal Facility of
the Hannover Medical School four weeks before the
beginning of the experiments.
The C57BL/6J strain was kept under specified pathogen-
free conditions. All other mouse strains were kept in indi-
vidually ventilated cages. The temperature was 21°C, the
relative humidity 55 ± 5%. The C57BL/6J strain was fed an
irradiated standard chow (ssniff R-Z V1324-300) and
autoclaved water ad libitum. The other mouse strains were
fed a different irradiated standard chow (altromin 1314)
and filtered water also ad libitum. Litter size and number
of litters were recorded for all breeding pairs housed at
Hannover Medical School.
Genotyping of mice
High molecular weight DNA was isolated from murine
liver tissue based on the protocol by Gross-Bellard et al.
[30]. Mice were genotyped by a low density SNP scan
(Kbiosciences, Hoddesdon, England), microsatellites and
PCR spanning the integration sites of the pMC1neoPolyA
vector in exon 10 of Cftr [9]. Microsatellites were ampli-
fied by PCR from genomic DNA, separated by direct blot-
ting electrophoresis [9] and evaluated as outlined by
Mekus et al. [31].
During the generation of the congenic strains, the inser-
tion of the vector was verified for all litters by Southern
blot hybridizations [4,9]. This control was necessary
because the spontaneous excision of the vector has been
observed at a frequency of 4–5% in heterozygous carriers
of the insertion mutation [9].BMC Genetics 2008, 9:28 http://www.biomedcentral.com/1471-2156/9/28
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Short circuit current measurements
Freshly excised mouse ileum, colon and nasal epithelium
of CF/1, CF/3, D2-CF/3 and B6-CF/3 homozygous ani-
mals were used for short circuit current (Isc) measure-
ments and compared with wild type controls.
Experiments were performed at 37°C. The perfusion solu-
tion was saturated with 95% O2 and 5% CO2, pH 7.4.
Modified Meyler's solution (128 mM NaCl, 4.7 mM KCl,
1.3 mM CaCl2, 1.0 mM MgCl2, 20.2 mM NaHCO3, 0.4
mM NaH2PO4, 0.33 mM Na2HPO4, 10 mM HEPES) was
used for the measurements on ileum and nasal epithe-
lium, and Krebs-Henseleit solution (113.6 mM NaCl, 5.4
mM KCl, 1.2 mM CaCl2, 1.2 mM MgCl2, 0.6 mM
NaH2PO4, 2.4 mM Na2HPO4, 21.0 mM NaHCO3, 10.0
mM glucose and 19.7 mM mannitol) was used for the
measurements on colon epithelium.
Mouse ileum or colon was excised under hypnorm/
diazepam anaesthesia and reverted on a plastic rod. The
muscle layer was cut longitudinally using a blunt razor
blade and was stripped of fat manually. The stripped tis-
sue was mounted in a holder with the mucosal side up
(exposed tissue area 0.2 or 0.5 cm2). After insertion of the
holder into the Ussing chamber the tissue was allowed to
recover for 10–20 min and to reach a stable baseline. The
tissues were then short-circuited for the whole experimen-
tal period.
In case of ileum tissue specimens, glucose (10 mM) and
indomethacin (10 µM) were added to the serosal side.
After equilibrium, the following compounds were added
consecutively to the mucosal (M) or serosal (S) side of the
tissue: Forskolin (10 µM, S), genistein (100 µM, M+S) and
carbachol (200 µM, S). All compounds were present
throughout the experiment. Experiments on the colon
were performed with a proximal and a distal specimen of
colon ascendens in each wild type and CF mouse. After
equilibration the following drugs were sequentially
added: amiloride (100 µM, M), TEA (tetraethylammo-
nium, 5 mM, M), Ba2+ (BaCl2, 1 mM, M), DIDS (4,4'-dii-
sothiocyanostilbene-2,2'-disulfonic acid, 200 µM, M) and
carbachol (100 µM, S).
Mouse nasal epithelium was isolated as described by
Grubb et al. [32]. In brief, the mice were sacrificed by cer-
vical dislocation and the skin of the head was peeled back
in order to reach the underlying paired nasal bones. These
were removed and the two sheets of the nasal epithelia,
separated by the septum, were isolated independently.
The sheets of epithelia were mounted immediately
between the Ussing chambers (exposed area 1.13 mm2).
The chambers were filled with gassed modified Meyler's
solution supplemented with glucose (10 mM) and
indomethacin (10 µM) and the short circuit measure-
ments were started. After equilibration amiloride (10 µM,
M) was added followed by forskolin (10 µM, S, after sta-
bilization of the current).
Statistics
Data are presented as means ± standard deviation (SD), n
represents the number of mice. Unpaired t-test was used
for comparisons between two groups. One-way ANOVA
followed by a post hoc Tukey's test was applied for com-
parisons within one group. P-values < 0.05 were consid-
ered to be significant. The statistical analysis was
performed using GraphPad Prism version 4.00 for Win-
dows.
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